Research study Program year 2019 Source: CMS Open Payments

Gam5-28

ClinicalTrials.gov NCT01859754

Research payments

$254,817

60 payments

Through program year 2019, $254,817 in research payments was reported against Gam5-28, across 60 payments, paid by Octapharma USA, Inc..

Paid by: Octapharma USA, Inc.
ClinicalTrials.gov: NCT01859754

By program year

1 row

Year	Kind	Amount	Payments
2019	Research	$254,817	60

Breakdown

Who paid Research payments · program year 2019

Octapharma USA, Inc. $254,817 60 payments

Who received the money Research payments · program year 2019

Fort Wayne Medical Institute Organisation paid for research $55,000 5 payments
Immunoe Research Centers Organisation paid for research $49,946 6 payments
Infectious Disease Consultants Organisation paid for research $24,089 2 payments
The Toledo Institute Of Clinical Research INC Organisation paid for research $13,491 5 payments
Optimed Research Ltd Organisation paid for research $12,390 1 payment
Allergy Asthma & Immunology Clinic PA Organisation paid for research $11,544 4 payments
The Regents Of The University Of California Irvine Organisation paid for research $11,272 1 payment
Ohio Clinical Research Associates Organisation paid for research $10,700 3 payments
Institute For Allergy & Asthma Pc Organisation paid for research $10,236 2 payments
Midwest Immunology Clinic Organisation paid for research $6,600 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.